Pradaxa® (dabigatran etexilate) is an anticoagulant. Anticoagulants work by slowing the clotting process, reducing the chance of clots from forming. It helps to reduce your risk of stroke because clots are less likely to form and travel to your brain, causing a stroke.

As this medicine affects blood clotting, most side effects are related to signs such as bruising or bleeding. If you are bleeding heavily or for a long time or if you have exceptional weakness, tiredness, paleness, dizziness, headache or unexplained swelling then please contact your doctor straight away.

The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.

Please click on the links below to view the PIL.

Pradaxa®
150mg

Twice daily

Pradaxa®
110mg

Twice daily

Please click on the links below to view the Pradaxa® Summary of Product Characteristics (SmPC).

Pradaxa®
150mg

SmPC

Pradaxa®
110mg

SmPC

Please click on the link below to view the Pradaxa® European Public Assessment Report (EPAR).

Pradaxa®

EPAR

Reporting side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet.

You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.

By reporting side effects you can help provide more information on the safety of this medicine.